Skip to main content
Premium Trial:

Request an Annual Quote

Accelr8, Schott Reach Diagnostics Licensing Deal

NEW YORK (GenomeWeb News) – Accelr8 has granted Schott Technical Glass Solutions a license to sell its OptiChem-coated products for medical diagnostic applications.

The companies also renewed a license to Schott covering the German company's Nexterion microarray slides using OptiChem biocoatings. The renewal extends through Nov. 24, 2014.

The new medical diagnostics deal gives Schott the rights to sell up to 20,000 units of OptiChem-coated products per year to any single customer. If the customer exceeds that figure, Schott will refer the customer to Accelr8 to negotiate a direct license from the Denver-based firm.

Schott is paying Accelr8 a license fee of $150,000 and non-recourse pre-paid royalties. Schott will pay additional cash royalties to Accelr8 after Schott has met cumulative sales that generate the pre-paid royalty amount, the two firms said.

Accelr8 also has a licensing deal with Nanosphere in medical diagnostics.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.